Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Geoffrey S Dow is President and CEO at 60 Degrees Pharmaceuticals. OQRO lists 10 transactions filed with the SEC under this name, the latest on Jun 16, 2026, each linked to the official Form 4.
President and CEO
Disclosures on record
10
Companies involved
1
5 buys, median −39.9 pts vs S&P 500, beat it 0 of 5 times.
Average −46.3 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 21, 2024 to Jun 16, 2026, measured from the first close after the filing. Past results, not a forecast.
5 purchases disclosed; 0% of the 5 measured at 90 days finished ahead of the index. $1,000 placed after each of the 3 purchases disclosed since 2025-11-14 would be worth $632 today ($3K put in); the same in the S&P 500 (SPY): $3.2K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
60 Degrees PharmaceuticalsSXTP
10 disclosures · Nov 2024 – Jun 2026 · 10 bought
Jun 12, 2026Bought~$10Kdisclosed Jun 16
DetailsOfficial recordDec 15, 2025Bought~$7.8Kdisclosed Dec 17
DetailsOfficial recordDec 10, 2025Bought~$8.9Kdisclosed Dec 12
DetailsOfficial recordDec 11, 2025Bought~$3.3Kdisclosed Dec 12
DetailsOfficial recordDec 9, 2024Bought~$46K
DetailsOfficial recordDec 6, 2024Bought~$25Kdisclosed Dec 9
DetailsOfficial recordDec 5, 2024Bought~$20Kdisclosed Dec 9
DetailsOfficial recordNov 19, 2024Bought~$2.2Kdisclosed Nov 21
DetailsOfficial recordNov 21, 2024Bought~$3.2K
DetailsOfficial recordNov 20, 2024Bought~$924disclosed Nov 21
DetailsOfficial recordAs of the latest filing on , Geoffrey S Dow reported holding 24,131 shares of 60 Degrees Pharmaceuticals (SXTP), worth about $12K at the last close of $1 (Nov 13, 2026). In the last 12 months, Geoffrey S Dow bought $30K in 4 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| 60 Degrees Pharmaceuticals SXTP | 24,131 | 24K direct | $1 | $12K | Jun 12, 2026 |
Is this Geoffrey S Dow’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Geoffrey S Dow bought shares on the open market in 2024, 2025 and 2026.
Geoffrey S Dow reported 11 open-market purchases and 0 sales since 2024; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $10K1×1 trade | — |
| 2025 | $20K3×3 trades | — |
| 2024 | $106K7×7 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Jun 12, 2026, Geoffrey S Dow reported holding 24,131 shares of 60 Degrees Pharmaceuticals (SXTP). At the last close of $1 on Nov 13, 2026, that is about $12K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Geoffrey S Dow reported 4 open-market purchases worth $30K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Geoffrey S Dow bought shares on the open market in 2024, 2025 and 2026.
In SEC filings since 2024: the latest open-market purchase is from 2026; no open-market sale is on record.
60 Degrees Pharmaceuticals (SXTP), from 2024 to 2026: 11 purchases and 0 sales.
Geoffrey S Dow reported 11 open-market purchases and 0 sales here, 2024 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.